Overview of this trial
Why was the research needed? ...............................Page 3
Researchers are looking for a better way to treat advanced breast cancer.
Before a drug can be approved for people to take, researchers do clinical
trials to find out how it works and how safe it is.
What treatments did the participants take? ...........Page 5
The participants in this trial took olaparib.
What were the results of this trial? .........................Page 7
The main questions the researchers wanted to answer in this trial were:
X How long did the participants live without their cancer becoming
worse after they started taking olaparib?
Overall, the participants lived for 8.2 months without their cancer
becoming worse after taking olaparib.
X How long did the participants live after they started taking
olaparib?
Overall, the participants lived for 24.9 months after taking
olaparib.
What medical problems did the doctors report
as possibly related to the trial treatment? ..............Page 8
There were 85.1% of participants who had medical problems that the
trial doctors reported as possibly being related to the trial drug. This was
217 out of 255 participants.
More details about the medical problems from this trial are included later
in this summary.
Where can I learn more about this trial? ...............Page 12
You can find more information about this trial on the websites listed on
the last page. When a full report of the trial results is available, it can also
be found on those websites.
2 | Clinical Trial Results